Radium-223: a new treatment option for bone-metastatic CRPC

被引：0
|
作者：
Petros D. Grivas
Evan T. Keller
机构：
[1] C353 Med Inn Building,Division of Hematology/Oncology, Department of Internal Medicine
[2] SPC 5848,Department of Urology
[3] University of Michigan,undefined
[4] Room 5308,undefined
[5] Cancer Center,undefined
[6] University of Michigan,undefined
来源：
Nature Reviews Urology | 2013年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Radium-223 is an emitter of high-energy α particles that binds selectively to areas of high bone turnover. In a recently published phase III trial, it prolonged overall survival of patients with symptomatic, castration-resistant prostate cancer with bone metastases and, as a result, has gained FDA approval for this indication.
引用
收藏
页码：630 / 631
页数：1
相关论文
共 50 条
  • [1] PROSTATE CANCER Radium-223: a new treatment option for bone-metastatic CRPC
    Grivas, Petros D.
    Keller, Evan T.
    NATURE REVIEWS UROLOGY, 2013, 10 (11) : 630 - 631
  • [2] Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects
    Lewis, Brian
    Chalhoub, Elie
    Chalouhy, Carla
    Sartor, Oliver
    ONCOLOGY-NEW YORK, 2015, 29 (07): : 483 - 488
  • [3] Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
    Buroni, Federica Eleonora
    Persico, Marco Giovanni
    Pasi, Francesca
    Lodola, Lorenzo
    Nano, Rosanna
    Aprile, Carlo
    ANTICANCER RESEARCH, 2016, 36 (11) : 5719 - 5730
  • [4] Treatment of Metastatic Bone Disease and the Emerging Role of Radium-223
    Coleman, Robert
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (02) : 99 - 104
  • [5] Imaging and pharmacokinetics with escalating doses of Radium-223 chloride in bone-metastatic castration resistant prostate cancer (CRPC) during a phase I study
    Carrasquillo, Jorge
    O'Donoghue, Joseph
    Pandit-Taskar, Neeta
    Aksnes, Anne-Kirsti
    Larson, Steven
    Scher, Howard
    Morris, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [6] Radium-223 Chloride A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma
    Pinto, Alvaro
    Cruz, Patricia
    DRUGS IN R&D, 2012, 12 (04) : 227 - 233
  • [7] Radium-223 ChlorideA New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma
    Álvaro Pinto
    Patricia Cruz
    Drugs in R&D, 2012, 12 (4) : 227 - 233
  • [8] Radium-223 in the treatment of metastatic prostate cancer
    Marques, I. A.
    Abrantes, A. M.
    Pires, A. S.
    Costa, G.
    Tavares-Silva, E.
    Botelho, M. F.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S47 - S47
  • [9] Radium-223 dichloride for the treatment of metastatic prostate cancer
    Turner, Philip Geoffrey
    O'Sullivan, Joe
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (14) : 2105 - 2111
  • [10] Radium-223 and bone metastatic disease: still more to learn
    Sartor, Oliver
    JNCI CANCER SPECTRUM, 2023, 7 (06)
12345